{"id":"https://openalex.org/W4414101950","doi":"https://doi.org/10.1158/2767-9764.30093348","title":"Supplementary Data File 1 from A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3\u2013Expressing Relapsed or Refractory Solid Tumors","display_name":"Supplementary Data File 1 from A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3\u2013Expressing Relapsed or Refractory Solid Tumors","publication_year":2025,"publication_date":"2025-09-10","ids":{"openalex":"https://openalex.org/W4414101950","doi":"https://doi.org/10.1158/2767-9764.30093348"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.30093348","doi":"https://doi.org/10.1158/2767-9764.30093348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30093348","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_File_1_from_A_Phase_I_Open-Label_Dose_Escalation_Study_of_Enoblituzumab_in_Children_and_Young_Adults_with_B7-H3_Expressing_Relapsed_or_Refractory_Solid_Tumors/30093348/1/files/57822747.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_File_1_from_A_Phase_I_Open-Label_Dose_Escalation_Study_of_Enoblituzumab_in_Children_and_Young_Adults_with_B7-H3_Expressing_Relapsed_or_Refractory_Solid_Tumors/30093348/1/files/57822747.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068262775","display_name":"Kenneth B. DeSantes","orcid":"https://orcid.org/0000-0002-9092-0139","observed_orcids":["https://orcid.org/0000-0002-9092-0139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth B. DeSantes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9092-0139","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108426933","display_name":"Kimberly A. McDowell","orcid":"https://orcid.org/0009-0000-5412-105X","observed_orcids":["https://orcid.org/0009-0000-5412-105X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly A. McDowell","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-5412-105X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011569932","display_name":"Paul M. Sondel","orcid":"https://orcid.org/0000-0002-0981-8875","observed_orcids":["https://orcid.org/0000-0002-0981-8875"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul M. Sondel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0981-8875","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088507656","display_name":"Paul R. Hutson","orcid":"https://orcid.org/0000-0002-6968-7096","observed_orcids":["https://orcid.org/0000-0002-6968-7096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul R. Hutson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6968-7096","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021388942","display_name":"Rosandra Natasha Kaplan","orcid":"https://orcid.org/0000-0002-8580-0001","observed_orcids":["https://orcid.org/0000-0002-8580-0001"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosandra N. Kaplan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8580-0001","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017501517","display_name":"Julie R. Park","orcid":"https://orcid.org/0000-0002-6777-9165","observed_orcids":["https://orcid.org/0000-0002-6777-9165"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie R. Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6777-9165","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032050779","display_name":"Meenakshi G. Hegde","orcid":"https://orcid.org/0000-0002-7778-7871","observed_orcids":["https://orcid.org/0000-0002-7778-7871"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meenakshi G. Hegde","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7778-7871","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087779758","display_name":"Crystal Lee Mackall","orcid":"https://orcid.org/0000-0003-0359-9023","observed_orcids":["https://orcid.org/0000-0003-0359-9023","https://orcid.org/0000-0001-6323-4304"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Crystal L. Mackall","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0359-9023","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005797590","display_name":"John M. Maris","orcid":"https://orcid.org/0000-0002-8088-7929","observed_orcids":["https://orcid.org/0000-0002-8088-7929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Maris","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8088-7929","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6880000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.06350000202655792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.05469999834895134,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b7-h3","display_name":"B7-H3","score":0.9739999771118164},{"id":"https://openalex.org/keywords/relapsed-or-refractory-solid-tumors","display_name":"relapsed or refractory solid tumors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8259999752044678},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.531000018119812},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4970000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7527999877929688},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.6656000018119812},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.6635000109672546},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4074000120162964},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38839998841285706},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.3264000117778778},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.3018999993801117},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.28780001401901245},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2734000086784363},{"id":"https://openalex.org/C171730128","wikidata":"https://www.wikidata.org/wiki/Q5227290","display_name":"Data file","level":2,"score":0.2498999983072281}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/2767-9764.30093348","doi":"https://doi.org/10.1158/2767-9764.30093348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30093348","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_File_1_from_A_Phase_I_Open-Label_Dose_Escalation_Study_of_Enoblituzumab_in_Children_and_Young_Adults_with_B7-H3_Expressing_Relapsed_or_Refractory_Solid_Tumors/30093348/1/files/57822747.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/30093348","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Data_File_1_from_A_Phase_I_Open-Label_Dose_Escalation_Study_of_Enoblituzumab_in_Children_and_Young_Adults_with_B7-H3_Expressing_Relapsed_or_Refractory_Solid_Tumors/30093348","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.30093348","doi":"https://doi.org/10.1158/2767-9764.30093348","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.30093348","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_File_1_from_A_Phase_I_Open-Label_Dose_Escalation_Study_of_Enoblituzumab_in_Children_and_Young_Adults_with_B7-H3_Expressing_Relapsed_or_Refractory_Solid_Tumors/30093348/1/files/57822747.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4414101950.pdf","grobid_xml":"https://content.openalex.org/works/W4414101950.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899084033","https://openalex.org/W2748952813","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762","https://openalex.org/W1995515455","https://openalex.org/W2080531066","https://openalex.org/W3108674512","https://openalex.org/W1506200166","https://openalex.org/W1489783725"],"abstract_inverted_index":{"DLT":[0],"Definitions":[1]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}